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With an increasing proportion of the population reaching
advanced age, cardiovascular disease" has become an urgent
public health concern because it is among the most common
and disabling cause of physical impairments that afflict the
elderly. Elimin ation of the morb idity associated with car-
diovascular disease throu gh preventive measures would do
much to dec rease chronic disability and to improve the qual-
ity of the last years of life.
The incidence of most clinical manifestations of cardio-
vascular disease incre ases dramatically with advanced age.
and women tend to lose much of their risk advantage over
men. Cardiovascular diseases, including coronary heart dis-
ease , stroke , cardiac failure and peripheral arterial disease ,
account for most of the mortality in the senium . However .
cardiovascular disease should not be considered an inevi-
table concomitant of the aging process. Autopsy in the el-
derly, even the very aged , often reveals atheroma-free coro-
nary arteries, a normal -sized heart and unscarred valves ( I).
Risk Factors in the Elderly
Most risk factors known to contribute to cardiovascular
disease are highly prevalent in the aged . These include hy-
pertension , elevated cholesterol levels , diabetes, obes ity and
physical inactivity . Only cigarette smoking appears to de-
cline with advancing age . Althou gh these risk factors are
all modifiable, doubt has been expressed as to the relevance
or risk modification in the elderly . It is universally accepted
that the risk of cardiovascular disease in middle life can be
predicted from a readily assembled profile including arterial
hypertension, cigarette smoking, hypercholesterolemia , di-
abetes, obesity, physical inactivity , a family history of pre-
mature cardi ovascular disease and , possibly , type A behav-
ior. Data from Framingham (2-6) and other epidemiologic
studies clearly demonstrate that most risk factors continue
to contribute to cardiovascular disease incidence in older
persons (Table I). However. there appear to be some dif-
' This principally encompasses coronary heart disease , stroke. cardiac
failure and peripheral arterial disease.
';1)1987 by [he American College of Cardiology
ferenees in the risk associations for certain factor s in the
elderly.
Serum cholesterol level. Although total serum choles-
terol level loses strength as a predictor of cardiovascular
disease in older persons , fractionation of chole sterol into its
low and high density lipoprotein components restore s the
predicti ve value of these lipid levels (Table 2) (7) . This
suggests that blood lipid levels continue to influence the
rate of thromboatherogenesis in the aged and that a fat-
modified diet may be of preventive value , particularly if
continued from an earlier age .
Cigarette smoking. The influence of cigarette smoking
on cardiovascular disease in general diminishes with ad-
vancing age. However, cigarette smoking remains a sig-
nificant risk factor for intermittent claudication and stroke
(3- 6) for both men and women .
Diabetes. Diabetes make s an independent contribution
to cardiovascular risk , particularly in older women (8 ,9) .
Its influence on cardiovascular disease is undiminished in
advanced age (Tabl e I) . Diabetes in women markedly de-
creases the female risk advantage over that of men.
Obesity. Substantial obesity , particularly with a central
fat distribution . predisposes to cardiovascular disease in the
elderly (4, 10).
Hypertension. The risk of arterial pressure elevation is
not linear but exponential; the curve slopes upward with
advancing age . Age itself is as potent a predictor of a car-
diovascular end point as is arter ial pressure . Elevated sys-
tolic blood pressure that continues to rise progressively with
advancing age confers a substantial risk for all major forms
of cardiovascular disease in the elderly . irrespective of the
level of diastolic pressure . Elevated diastolic pressure is
common and is also hazardou s in the elderl y.
ECG abnormalities. The electrocardiogram (ECG ) is
useful in predicting cardiovascular disea se in the elderly
( 11.12). ECG evidence of left ventricular hypertrophy . in-
traventr icular conduction disturbances and repol arization
abnormalities all predict cardiovascular disease in the el-
derly (Table I).
Vital capacity. Vital capa city declin es with age , and is
worsened by cigarette smoking (13, 14). When diminished.
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Table 1. Impact of Risk Factors on Cardiovascular Disease Incidence" by Age in Men and
Women at 30 Year Follow-up: Framingham Study
Multivariate Logistic Regression Coefficients] at
Age 35 to 64* Age 65 to 94=1:
Risk Factor Men Women Men Women
Systolic pressure 341§ 0.361 § 0.4109 0.207§
Diastolic pressure 0.3029 0.28~11 0.259§ 0.089**
Serum cholesterol 0.230§ 0.202§ 0.09'# 0.040**
Blood glucose 0.0~7" 0.17M 0.146§ 0.173§
Relative weight 0.080" 0.13411 0.044** 0.052**
Vital capacity -0.089" -0.252§ - 0.109** -0.216§
Cigarettes 0.333§ 0.1839 0.045** 0.083**
ECG-LYH 0.121§ 0.112§ 0.142§ 0.229§
Intraventricular 0.049** 0.075" 0.096" 0.096"
block
NSA-ST-T 0.052** 0.130§ 0.187§ 0.147§
"Coronary events, stroke, cardiac failure and peripheral arterial disease. tCovariates for each variable cited
in Risk Factor column: blood pressure, cholesterol, cigarettes and electrocardiographic evidence of left ven-
tricular hypertrophy. tAge at biennial examination. §p < 0.001: lip < 0.01: "p < 0.05: **not significant.
ECG-LVH = electrocardiographic evidence of left ventricular hypertrophy; NSA-ST-T = nonspecific ST
segment and T wave abnormalities.
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it is strikingly associated With the excessive development
of cardiovascular disease (15). It is a powerful predictor of
cardiac failure.
Heart rate. A rapid heart rate at rest, that is, >84
beats/min, also indicates an increased risk of cardiovascular
disease, including cardiac failure, coronary disease and sud-
den death (4).
Cardiovascular risk profiles. These profiles, consisting
of the standard risk factors, retain usefulness in older per-
sons, defining risk over a wide range. These profiles may
identify individuals with increased risk due to multiple bor-
derline abnormalities, individuals who would otherwise not
be detected (16). Despite a lesser relative impact of some
risk factors in advanced age, these risk profiles are nearly
as efficient in predicting cardiovascular disease in the elderly
as in younger persons (2,4) (Table 3). Profiles that also
Table 2. Influence of Serum Lipids on Coronary Heart Disease
Incidence in Elderly Men and Women 50 to 82 Years of Age at
4 Year Follow-Up: Framingham Study
include low and high density lipoprotein cholesterol subfrac-
tions, vital capacity and heart rate may enhance precision
in predicting cardiovascular disease in the elderly,
Preventive Recommendations
Ideally, preventive measures should be initiated early in
life to reduce the ultimate burden of cardiovascular disease
in both young and old, but such measures instituted in the
aged should not be considered valueless. The incidence of
cardiovascular disease in older persons varies widely in
relation to modifiable risk factors. Because incidence rates
of cardiovascular disease are high in the elderly, preventive
measures could have a substantial impact on older persons.
The decline in cardiovascular mortality in the United
States and some other industrialized nations also has in-
Table j, Efficiency of Coronary Risk Profile"
by Age and Sex at 16 Year follow-up:
Framingham Study
Standardized Logistic Multivariate
Coefficients"
Men Women
Percent of Coronary Events
in Top Decile of
Multivariate Risk
Cholesterol
High density
Low density
Triglyceride
-0.61O·r
0.332:;:
"0.092
- 0.650t
0.260§
-0.106
Age (yr)
45 to 54
55 to 64
65 to 74
Men
26
27
21
Women
20
26
41
*Covariates: systolic blood pressure, electrocardiographic evidence of
left ventricular hypertrophy, relative weight and diabetes. tp < 0.001;
+P < 0.01: §p < 0.05. (Reprinted with permission from Gordon T. et al.
[7].)
*Based on: systolic blood pressure, serum choles-
terol, number of cigarettes smoked/day, glucose toler-
ance and electrocardiographic evidence of left ventric-
ular hypertrophy.
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Table 4. Declines in U.S. Cardiovascular Mortality 1963
to ]981
Percent of Decline by Age
Coronary Stroke
Age (yr) Mortality Mortality
35 to 44 45 46
45 to .14 38 42
55 to 64 38 S1
f>S tn 74 17 53
75 to 84 10 50
2c85 26 44
From the National Center for Health Statistics. adjusted for seventh
revision of the International Classification of Diseases.
volved the elderly (Table 4). This indicates that environ-
mental influences on cardiovascular disease incidence ex-
tend to older persons. These secular trends in mortality are
correlated with corresponding changes in known risk factors
for cardiovascular disease in both young and old (17,18).
Thus, comprehensive risk factor modification seems a rea-
sonable option in older as well as younger persons.
Most cardiovascular disease risk factors, including hy-
pertension. dyslipidernia, impaired glucose tolerance, cig-
arette smoking, obesity and physical deconditioning, are
both highly prevalent and modifiable in the elderly.
Dietary change, weight control, avoidance of cigarettes
and treatment of hypertension can favorably influence the
risk profile of the elderly. Although no randomized con-
trolled trials have been performed on modification of risk
factors in the elderly except for hypertension (37-40), op-
timism as to likely efficacy is justified (19-21).
Control of dyslipidemia, obesity and diabetes. Serum
total and low density lipoprotein cholesterol can be lowered
by decreased intake of cholesterol and saturated fat, with
partial replacement of the saturated fat by polyunsaturated
fat from vegetable and fish sources, by increased intake of
water-soluble fiber and by reduction of overweight (19-21).
Recent studies have shown a relation between the quantity
and character of dietary fats, including fish oils, and coro-
nary heart disease mortality (22-24). At least two recently
completed controlled trials in younger populations have shown
that reducing serum cholesterol by diet and drugs can lower
coronary morbidity and mortality (25,26). The fat-modified
diets required are nutritionally adequate, safe, convenient,
inexpensive and palatable. Obesity aggravates all athero-
genic traits in both young and old. Weight control with a
well balanced fat-modified diet is a major hygienic approach
for improving all the atherogenic risk factors in young and
old people (27-31). Preventive measures for the elderly
diabetic at high risk for cardiovascular disease should in-
clude reduction of overweight; control of elevated blood
pressure by dietary and, if needed, drug therapy; control of
blood lipids and avoidance of cigarette smoking, in addition
to control of blood sugar.
Cigarette smoking. It is likely that smoking contributes
to thrombotic occlusion and is a risk factor for occlusive
peripheral arterial disease in the elderly (3-6,32). Cigarette
smoking is also a major contributor to chronic bronchitis,
emphysema and lung cancer in the elderly.
Regular physical activity. This should be encouraged
in the elderly because overall and cardiovascular mortality
rates apparently are benefited at all ages, including the el-
derly (33,34).
Control of hypertension. Hypertension is a major re-
mediable risk factor for cardiovascular disease in the elderly
because of its high prevalence and sustained impact in ad-
vanced age (35,36). Hypertension control should lessen the
incidence of stroke, cardiac failure and renal insufficiency
(37-44). Although the efficacy of correcting isolated sys-
tolic hypertension has not been demonstrated, its impact on
risk in the elderly is established, early experience with its
treatment is encouraging and a full-scale controlled trial is
underway (35,36,41-44).
Impediments to Preventive Approaches in
the Elderly
There are a number of impediments to implementing
preventive programs for cardiovascular disease in the el-
derly. Foremost is the propriety of modifying life styles
already compatible with superior longevity. The psycho-
logic and social impacts of such interventions are not known.
Common sense dictates a conservative, individualized ap-
proach, particularly in the very old. However, the elderly
are good consumers of health education and they comply
with advice at least as enthusiastically as younger adults.
Correspondingly, physicians should be encouraged to give
hygienic advice to the elderly and to aid them in improving
living habits. Regrettably, many regard cardiovascular dis-
ease in the elderly as inevitable and do not think that in-
grained habits can be changed. Patients and their families
often regard the infirmities of old age as an inevitable burden
that must be endured. There is a reluctance to undertake
uncomfortable or expensive procedures. The result is some-
times indifference or benign neglect. Ethical considerations
mandate that persons identified by risk profiling as vulner-
able to cardiovascular disease should be counseled to modify
their life-styles appropriately. The aged who require such
interventions can be identified by ordinary office procedures
and simple laboratory tests on routine health examinations.
Physicians experienced in the care of the elderly observe
that most elderly persons are concerned about their health,
follow therapeutic recommendations closely and adhere to
prescribed medications at least as well as younger persons.
Preventive approaches are feasible, and can profitably and
28A KANNEL ET AL.
PREVENTION
JACC Vol. 10, No.2
August 1987:25A-28A
appropriately be extended to the growing older segment of
the population.
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